메뉴 건너뛰기
Journal of Clinical Psychiatry
Volumn 75, Issue 10, 2014, Pages e1140-e1141
Metformin for weight loss and control in patients with mood disorder
Author keywords

[No Author keywords available]
Indexed keywords

METFORMIN; NEUROLEPTIC AGENT; QUETIAPINE; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; DIBENZOTHIAZEPINE DERIVATIVE;
EID: 84922395195     PISSN: 01606689     EISSN: 15552101     Source Type: Journal    
DOI: 10.4088/JCP.14cr09133     Document Type: Note
Times cited : (2)
References (6)
  • 1
    • 79957794555 scopus 로고    scopus 로고
    • Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder
    • PubMed
    • Citrome L, Holt RI, Walker DJ, et al. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder. Clin Drug Investig. 2011;31(7):455-482. doi:10.2165/1589060-0-0 PubMed
    • (2011) Clin Drug Investig. , vol.31 , Issue.7 , pp. 455-482
    • Citrome, L.1    Holt, R.I.2    Walker, D.J.3
  • 2
    • 58849138816 scopus 로고    scopus 로고
    • Which comes first: Atypical antipsychotic treatment or cardiometabolic risk?
    • PubMed
    • Stahl SM, Mignon L, Meyer JM. Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Acta Psychiatr Scand. 2009;119(3):171-179. doi:10.1/j.160-047.208.0134.x PubMed
    • (2009) Acta Psychiatr Scand , vol.119 , Issue.3 , pp. 171-179
    • Stahl, S.M.1    Mignon, L.2    Meyer, J.M.3
  • 3
    • 84883728317 scopus 로고    scopus 로고
    • Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder
    • PubMed
    • Jarskog LF, Hamer RM, Catellier DJ, et al; METS Investigators. Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder. Am J Psychiatry. 2013;170(9):1032-1040. doi:10.176/api.ajp.2013.12010127 PubMed
    • (2013) Am J Psychiatry. , vol.170 , Issue.9 , pp. 1032-1040
    • Jarskog, L.F.1    Hamer, R.M.2    Catellier, D.J.3
  • 4
    • 84864805808 scopus 로고    scopus 로고
    • Metformin for treatment of antipsychoticinduced amenorrhea and weight gain in women with first-episode schizophrenia: A double-blind, randomized, placebo-controlled study
    • PubMed
    • Wu RR, Jin H, Gao K, et al. Metformin for treatment of antipsychoticinduced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 2012;169(8):813-821. doi:10.176/api.ajp.2012.1091432 PubMed
    • (2012) Am J Psychiatry. , vol.169 , Issue.8 , pp. 813-821
    • Wu, R.R.1    Jin, H.2    Gao, K.3
  • 5
    • 84883686021 scopus 로고    scopus 로고
    • Metformin for antipsychotic-related weight gain and metabolic abnormalities: When, for whom, and for how long?
    • PubMed
    • Correll CU, Sikich L, Reeves G, et al. Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long? Am J Psychiatry. 2013;170(9):947-952. doi:10.176/api.ajp.2013.1306071 PubMed
    • (2013) Am J Psychiatry , vol.170 , Issue.9 , pp. 947-952
    • Correll, C.U.1    Sikich, L.2    Reeves, G.3
  • 6
    • 84856419323 scopus 로고    scopus 로고
    • Efficacy of metformin for prevention of weight gain in psychiatric populations: A review
    • PubMed
    • Newall H, Myles N, Ward PB, et al. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review. Int Clin Psychopharmacol. 2012;27(2):69-75. doi:10.1097/YIC.0b013e32834d0a5b PubMed
    • (2012) Int Clin Psychopharmacol. , vol.27 , Issue.2 , pp. 69-75
    • Newall, H.1    Myles, N.2    Ward, P.B.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.